Adastra Holdings Ltd.

OTC: XTXXF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Langley, BCCIK 0001891512Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 25

v0.1 · 5/100 weight · pillars only

↑ return on assets, Piotroski F · ↓ filing timeliness, listing tenure

Methodology →

Revenue TTM

$12.0M

Rev growth YoY (TTM)

-35.7%

Net income (FY)

-$3.3M

Employees

Market cap

$39.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$3.3M-4.3M CAD2022

Total assets$23.5M31.8M CAD2022

Liabilities$10.0M13.6M CAD2022

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Adastra Holdings Ltd. earned -$3.3M in FY2022 net income.

Peers · Healthcare

Petlife Pharmaceuticals, Inc.——Profile Solutions, Inc.——Marizyme, Inc.——Interactive Health Network——

Key facts

CEOBrian O'Neill

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersLangley, BC

ExchangeOTC: XTXXF

Employees21

IPO date2021-07-19

Latest filings

6-K2023-12-06 6-K2023-08-18 6-K2023-05-31 20-F2023-05-17 6-K2023-05-04 6-K2023-05-04 6-K2023-04-14 6-K2023-03-20

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.